Progenitor cells and retinal angiogenesis

Angiogenesis

Volumn 10, Issue 2, 2007, Pages 89-101

  Friedlander, Martin ^a   Dorrell, Michael I ^a   Ritter, Matthew R ^a   Marchetti, Valentina ^a   Moreno, Stacey K ^a   El Kalay, Mohammad ^a   Bird, Alan C ^b   Banin, Eyal ^c   Aguilar, Edith ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cell therapies; Ocular angiogenesis; Progenitors; Stem cells

Indexed keywords

ANGIOGENESIS; ARTICLE; ASTROCYTE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CELL THERAPY; ENDOTHELIUM CELL; GLIOSIS; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA NEOVASCULARIZATION; SALVAGE THERAPY;

ADULT; BONE MARROW CELLS; CORD BLOOD STEM CELL TRANSPLANTATION; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RETINAL DISEASES; RETINAL VESSELS; SAFETY; STEM CELL TRANSPLANTATION;

MUS;

EID: 33947320208     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-007-9070-4     Document Type: Article

References (75)

1. LeCouter J et al (2003) Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299(5608):890-893
2. Matsumoto K et al (2001) Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294(5542):559-563
3. Otani A et al (2004) Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage negative hematopoietic stem cells. J Clin Invest 114(6):765-774
4. Shen Q et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304(5675):1338-1340
5. Fidler IJ, Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79(2):185-188
6. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27-31
7. Aiello LP (1997) Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res 29(5):354-362
8. Miller JW (1997) Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 151(1):13-23
9. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267(16):10931-10934
10. Ashton N (1963) Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmol 47:521-538
11. Cogan DG, Toussaint D, Kuwabara T (1961) Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66:366-378
12. Porta M et al (1981) Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 20(6):597-601
13. Photocoagulation treatment of proliferative diabetic retinopathy. (1981) Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8. The diabetic retinopathy study research group. Ophthalmology 88(7):583-600
14. Group ETDRSR (1991) Early Photocoagulation for diabetic retinopathy. Ophthalmology 98:766-785
15. Clover GM (1984) Laser treatment of diabetic maculopathy and the implications for retinal vascular barriers in Ophthalmology. London University, London
16. Haritoglou C et al (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26(9):999-1005
17. Mason JO 3rd, Nixon PA, White MF (2006) Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 142(4):685-688
18. Massin P et al (2004) Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111(2):218-224 discussion 224-225
19. Iturralde D et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26(3):279-284
20. Sydorova M, Lee MS (2005) Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Ophthalmic Res 37(4):188-190
21. McKay RD (2004) Stem cell biology and neurodegenerative disease. Philos Trans R Soc Lond B Biol Sci 359(1445):851-856
22. Asakura A (2003) Stem cells in adult skeletal muscle. Trends Cardiovasc Med 13(3):123-128
23. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9(6):702-712
24. Yamashita JK (2004) Differentiation and diversification of vascular cells from embryonic stem cells. Int J Hematol 80(1):1-6
25. Friedlander M (2006) Stem Cells. In: Ryan SJ (eds) Retina. Elsevier Mosby, Los Angeles, pp 23-32
26. Asahara T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967
27. Gill M et al (2001) Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88(2):167-174
28. Kalka C et al (2000) VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg 70(3):829-834
29. Kocher AA et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7(4):430-436
30. Grant MB et al (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8(6):607-612
31. Otani A et al (2002) Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8(9):1004-1010
32. Grant MB et al (2003) The contribution of adult hematopoietic stem cells to retinal neovascularization. Adv Exp Med Biol 522:37-45
33. Csaky KG et al (2004) Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor. Exp Eye Res 78(6):1107-1116
34. Espinosa-Heidmann DG et al (2003) Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44(11):4914-4919
35. Sengupta N et al (2003) The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest Ophthalmol Vis Sci 44(11):4908-4913
36. Filip SMJ, Karbanova J, Vavrova J, English D (2004) Local environmental factors determine hematopoietic differentiation of neural stem cells. Stem Cells Dev 13(1):113-120
37. Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23(7):845-856
38. Grunewald M et al (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124(1):175-189
39. Jin DK et al (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12(5):557-567
40. Ritter MR et al (2006) Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 116:3266-3276
41. Clausen BE et al (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8(4):265-277
42. Cramer T et al (2003) HIF-1alpha is essential for myeloid cellmediated inflammation. Cell 112(5):645-657
43. Checchin D et al (2006) Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci 47(8):3595-3602
44. Flamme I, Frolich T, Risau W (1997) Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173(2):206-210
45. Ferrara N (1999) Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 56(3):794-814
46. Tepper OM et al (2005) Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105(3):1068-1077
47. McKenney JK, Weiss SW, Folpe AL (2001) CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol 25(9):1167-1173
48. Miettinen M, Lindenmayer AE, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Yantigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7(1):82-90
49. Kreipe H et al (1986) Lectin binding and surface glycoprotein pattern of human macrophage populations. Histochemistry 86(2):201-206
50. Lougheed M et al (1999) Uptake of oxidized LDL by macrophages differs from that of acetyl LDL and leads to expansion of an acidic endolysosomal compartment. Arterioscler Thromb Vasc Biol 19(8):1881-1890
51. Rocha V, Gluckman E (2006) Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 12(1 Suppl 1):34-41
52. Broxmeyer HE (2005) Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 7(3):209-218
53. Nakahata T, Ogawa M (1982) Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 70(6):1324-81328
54. Broxmeyer HE et al (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86(10):3828-3832
55. Cardoso AA et al (1993) Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 90(18):8707-8711
56. Carow CE, Hangoc G, Broxmeyer HE (1993) Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood 81(4):942-949
57. Aoki M, Yasutake M, Murohara T (2004) Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22(6):994-1002
58. Murohara T et al (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105(11):1527-1536
59. Reyes M et al (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109(3):337-346
60. Hildbrand P et al (2004) The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 104(7):2010-2019
61. Crisa L et al (1999) Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94(11):3928-3940
62. Butler JM et al (2005) SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115(1):86-93
63. Ceradini DJ et al (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858-864
64. Sbaa E et al (2006) Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circ Res 98(9):1219-1227
65. Dorrell MI, Aguilar E, Friedlander M (2002) Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci 43(11):3500-3510
66. Dorrell MI et al (2004) Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina. Blood 103(9):3420-3427
67. Pettengell R et al (1993) Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82(12):3770-3777
68. Yamaji K, Tsuda H, Hashimoto H (2001) Current topics on cytapheresis technologies. Ther Apher 5(4):287-292
69. Weaver CH et al (1993) Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82(7):1981-1984
70. Boomsma RA, Swaminathan PD, Geenen DL (2006) Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int J Cardiol [Epub ahead of print]
71. Meluzin J et al (2006) Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 152(5):975 e9-15
72. Boyle AJ et al (2006) Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 109(1):21-27
73. Biosciences B BD FACSAria Technical Specifications
74. Weber JD (2004) Biosafety considerations for cell based therapies. BioPharm Int 17(7):48-61
75. Ford S, Tente WE (2001) Employing murine Mabs as ancillary products in cell therapy manufacturing. BioPharm Int 14(10):10-16